insulin and glp-1 agonist combination Fixed Ratio Overview - Combination Basal + GLP-1RA Therapy Practice Nursing - GLP-1 receptor

The GLP-1 receptor agonist market size was exhibited at USD 36.95 billion in 2023 and is projected to hit around USD 261.19 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2024 to 2033.

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

Here is what patients should know.

GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body that plays a crucial...

Product is not intended for weight loss.

It starts in the desert